Healthcare Services

Inherited Retinal Disease Market Expansion Outlook Through 2030 With Revenue Growth Insights

May 29, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

By 2030, How Much Growth In Market Size Is Expected For The Inherited Retinal Disease Market?

The inherited retinal disease market size has witnessed substantial expansion in recent years. This market is set to increase from $12.54 billion in 2025 to $13.6 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 8.4%. The expansion observed in the historic period can be ascribed to several factors, including the identification of disease-causing retinal genes, continuous advancements in retinal imaging technologies, a heightened awareness of inherited eye disorders, the establishment and growth of specialized ophthalmology clinics, and the availability of public and private funding for rare disease research.

The inherited retinal disease market is anticipated to experience robust expansion in the coming years, projected to reach $18.62 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 8.2%. This growth over the forecast period is largely driven by advancements in gene therapy platforms, a rise in approvals for novel retinal therapies, the increasing availability of genetic screening programs, the expansion of precision medicine initiatives, and growing investment in rare ophthalmic disease pipelines. Prominent trends expected during this forecast period include the increasing adoption of genetic testing for early diagnosis, a heightened focus on gene and cell-based therapies, the broadening of personalized treatment approaches, an increase in clinical trials for rare retinal disorders, and improved patient access to advanced retinal imaging.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20850&type=smp

What Major Growth Factors Are Impacting The Inherited Retinal Disease Market?

The rising occurrence of macular degeneration is anticipated to drive the expansion of the inherited retinal disease market moving forward. Macular degeneration is an age-related ophthalmic condition that damages the macula, leading to central vision impairment and difficulties with activities like reading or recognizing faces. The increasing incidence of macular degeneration is propelled by aging populations, longer life expectancies, and lifestyle factors such as smoking and poor nutrition, which escalate the risk. Treatment for inherited retinal disease benefits macular degeneration patients by targeting the fundamental genetic causes of retinal degeneration, offering therapies that can slow disease progression, restore lost vision, or even prevent additional damage to the retina, ultimately improving visual results and quality of life for individuals impacted by age-related or inherited types of macular degeneration. For instance, in February 2024, the Canadian Ophthalmological Society, a Canada-based nonprofit organization, reported that 2.5 million people in Canada aged over 55 lose their vision due to age-related macular degeneration (AMD). Consequently, the increasing prevalence of macular degeneration is fueling the growth of the inherited retinal disease market.

How Is The Inherited Retinal Disease Market Structured Across Different Market Segments?

The inherited retinal disease market covered in this report is segmented –

1) By Type: Diagnosis, Therapy

2) By Disease Type: Retinitis Pigmentosa, Choroideremia, Stargardt Disease, Cone-rod Dystrophy, Leber Congenital Amaurosis, Other Diseases

3) By Distribution Channel: Retail Sales, Direct Tender

4) By End User: Hospitals, Speciality Clinics, Ambulatory Surgical Centres, Home Healthcare, Other End Users

Subsegments:

1) By Diagnosis: Genetic Testing, Retinal Imaging, Electrophysiological Testing (Electroretinography), Visual Field Testing, Fundus Autofluorescence Imaging

2) By Therapy: Gene Therapy, Stem Cell Therapy, Retinal Prosthesis (Artificial Retina), Pharmacological Therapy, Photoreceptor Rescue Therapy

What Trends Are Influencing The Inherited Retinal Disease Market?

Leading companies in the inherited retinal diseases market are concentrating on developing innovative treatments, such as mutation-agnostic gene therapy, to offer inclusive treatment options and address a wider array of genetic variations linked to these conditions. Mutation-agnostic gene therapy represents a treatment approach that targets broader genetic mechanisms or pathways, rather than specific mutations, making it applicable across diverse genetic disorders. For instance, in March 2024, Nanoscope Therapeutics Inc, a US-based biotechnology company, reported favorable results from a clinical trial of its flagship program, MCO-010, demonstrating vision improvements for patients experiencing permanent and severe vision loss due to advanced retinitis pigmentosa. MCO-010 achieved both its primary and key secondary endpoints with statistical significance and no serious adverse events.

Who Are The Prominent Players Across The Inherited Retinal Disease Market?

Major companies operating in the inherited retinal disease market are Johnson & Johnson, Novartis AG, Astellas Pharma Inc., Biogen Inc., Ionis Pharmaceuticals Inc., Invitae Corporation, Spark Therapeutics, Aldeyra Therapeutics, Regenxbio Inc., IVERIC bio, MeiraGTx Limited, Ocugen Inc., Coave Therapeutics, Bionic Vision Technologies, GenSight Biologics SA, LKC Technologies Inc., Sparing Vision, ProQR Therapeutics NV, Endogena Therapeutics

Access The Complete Inherited Retinal Disease Market Report:

https://www.thebusinessresearchcompany.com/report/inherited-retinal-disease-global-market-report

Which Region Stands As The Largest Contributor To The Inherited Retinal Disease Market?

North America was the largest region in the inherited retinal disease market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the inherited retinal disease market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Inherited Retinal Disease Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=20850&type=smp

Browse Through More Reports Similar to the Global Inherited Retinal Disease Market 2026, By The Business Research Company

Influenza Vaccines Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/influenza-vaccines-global-market-report

Influenza Treatment Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/influenza-treatment-global-market-report

Infectious Disease Diagnostics Testing Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/infectious-disease-diagnostics-testing-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795